| Date | Stock | Signal | Target | Start Price | Best Price (1Y) | Accuracy | Current Price |
|---|---|---|---|---|---|---|---|
| Jul 10, 2026 |
Abbvie Inc
ABBV
|
BUY |
$280.00
Est. +13%
|
$246.80 | $260.88 |
Pending
|
$256.87
+4.1%
|
| Feb 24, 2026 |
Lilly(Eli) & Co
LLY
|
BUY |
$1,250.00
Est. +20%
|
$1,042.15 | $1,249.45 |
Bullseye Hit (±1%)
|
$1,185.77
+13.8%
|
| Feb 24, 2026 |
Merck & Co Inc
MRK
|
BUY |
$142.00
Est. +15%
|
$123.93 | $131.74 |
Pending
|
$130.46
+5.3%
|
| Feb 24, 2026 |
Abbvie Inc
ABBV
|
BUY |
$260.00
Est. +14%
|
$228.44 | $261.64 |
Bullseye Hit (±1%)
|
$256.87
+12.4%
|
| Feb 24, 2026 |
Bristol-Myers Squibb Co.
BMY
|
SELL |
$60.00
Est. +3%
|
$61.60 | $53.44 (Low) |
Target Met
|
$61.51
+0.1%
|
| Feb 24, 2026 |
Pfizer Inc.
PFE
|
SELL |
$25.00
Est. +8%
|
$27.14 | $23.62 (Low) |
Target Met
|
$25.01
+7.8%
|
| Oct 31, 2025 |
Insmed Inc
INSM
|
BUY |
$223.00
Est. +15%
|
$194.01 | $212.75 |
Pending
|
$107.41
-44.6%
|
| Jul 11, 2025 |
Regeneron Pharmaceuticals, Inc.
REGN
|
BUY |
$584.00
Est. +4%
|
$559.76 | $821.11 |
Target Met
|
$651.91
+16.5%
|
| May 02, 2025 |
Lilly(Eli) & Co
LLY
|
BUY |
$1,050.00
Est. +27%
|
$823.62 | $1,133.95 |
Target Met
|
$1,185.77
+44.0%
|
| May 02, 2025 |
AMGEN Inc.
AMGN
|
BUY |
$315.00
Est. +12%
|
$281.22 | $391.29 |
Target Met
|
$371.50
+32.1%
|
| Oct 09, 2024 |
Merck & Co Inc
MRK
|
BUY |
$136.00
Est. +25%
|
$108.88 | $111.58 |
Miss
|
$130.46
+19.8%
|
| Jul 12, 2024 |
Regeneron Pharmaceuticals, Inc.
REGN
|
BUY |
$1,250.00
Est. +14%
|
$1,092.31 | $1,211.20 |
Miss
|
$651.91
-40.3%
|
| Jul 12, 2024 |
Bristol-Myers Squibb Co.
BMY
|
BUY |
$43.00
Est. +6%
|
$40.68 | $63.33 |
Target Met
|
$61.51
+51.2%
|
| May 29, 2024 |
Insmed Inc
INSM
|
BUY |
$58.00
Est. +21%
|
$48.06 | $84.87 |
Target Met
|
$107.41
+123.5%
|
| Jul 21, 2023 |
Johnson & Johnson
JNJ
|
BUY |
$175.00
Est. +3%
|
$170.45 | $157.48 |
Miss
|
$259.27
+52.1%
|